Background. Dexmedetomidine (DEX), a selective agonist of a 2 -adrenergic receptors, is recognized to facilitate analgesia and anaesthesia in humans. Despite the potential for wide use, its effects on ion currents and membrane potential in neurones remain largely unclear.
Dexmedetomidine (DEX) is a potent and highly selective agonist of the a 2 -adrenergic receptors that is approved by the US Food and Drug Administration for the provision of short-term sedation of adult patients in the intensive care unit. It exerts a variety of actions on the human brain, including sedation, anaesthetic-sparing effects, and analgesia. 1 2 Because this agent has minimal effects on ventilation, it is relatively safe in the setting of functional neurosurgery. 3 Its sedative action is thought to involve inhibition of the locus coeruleus and subsequent disinhibition of the ventrolateral preoptic nucleus. 4 DEX has been reported to decrease the convulsive potency of bupivacaine and levobupivacaine in awake rats. 5 A recent study showed that as an anaesthetic adjunct, DEX at a high concentration can affect transcranial motor evoked responses. 6 However, there are limited reports regarding its ionic mechanism of action on neurones.
Recent evidence has emerged that the effects on ion channels may be an important mechanism underlying DEXinduced actions in neurones. For example, previous studies demonstrated the ability of DEX to modify L-type Ca 2+ current (I Ca,L ) in pheochromocytoma cells 7 and to inhibit M 3 muscarinic receptors in dorsal root ganglion cells. 8 In paraventricular nucleus neurones or substantia gelatinosa neurones, DEX increases G-protein-coupled inwardly rectifying K + current and inhibits hyperpolarization-elicited inward current. 9 10 Voltage-gated K + (K V ) channels play an essential role in determining the excitability of neurones.
Among them, delayed rectifier K + (K DR ) channels are ubiquitous in neurones. In fast-spiking neurones, a causal relationship between K V 3, especially K V 3.1, and the delayed rectifier K + current [I K(DR) ] has been well established. The K V 3 recombinant channel has properties suitable for the generation of high-frequency firing. High activation threshold (about 220 mV) and fast deactivation kinetics of the channels make them ideal for narrowing spike width and inter-spike interval. 11 The I K(DR) containing K V 3 subunits contributes to changes in membrane potential in differentiated NG108-15 cells. 12 -14 Previous studies in our laboratory have shown that tramadol suppresses the amplitude of I K(DR) in NG108-15 cells.
14 If K V 3-encoded K + currents are located at nerve terminals, modulation of current amplitude might be expected indirectly to alter Ca 2+ influx and to affect neurotransmitter release in the absence of overt changes in firing patterns. 11 15 However, whether DEX can interact with I K(DR) or other types of ion currents to modify membrane potential in neurones remains largely unclear, despite its clinical use in a variety of neurosurgical procedures. 2 -4 In this study, we investigated the effects of DEX on ion currents (e.g. delayed rectifier K + current [I K(DR) ], Na + current [I Na ], and L-type Ca 2+ current [I Ca,L ]) and membrane potential in NG108-15 neuronal cells differentiated with dibutyryl cyclic AMP and in cultured cerebellar neurones. DEX was able to suppress both I K(DR) and I Na . The major action of DEX on I K(DR) is thought to be through an open-channel mechanism. These inhibitory effects are not mediated by a 2 -adrenergic receptors and might contribute to its pharmacological actions in vivo.
Methods

Drugs and solutions
hydrochloride; Precedex w ) was obtained from Abbott Laboratories (Abbott Park, IL, USA). Collagenase, dibutyryl cyclic AMP, DNase I, efaroxan, tetraethylammonium chloride, and tetrodotoxin were purchased from Sigma Chemicals (St Louis, MO, USA), and yohimbine was from Tocris (Bristol, UK). Tissue culture media, L-glutamine penicillin-streptomycin, fungizone, and trypsin were obtained from Life Technologies (Carlsbad, CA, USA). All other chemicals, including CsCl 2 and CdCl 2 , were commercially available and of reagent grade.
The composition of normal Tyrode's solution was 136.5 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl 2 , 0.53 mM MgCl 2 , 5.5 mM glucose, and 5.5 mM HEPES -NaOH buffer, pH 7.4. To record I K(DR) or membrane potential, the patch pipette was filled with a solution consisting of 140 mM KCl, 1 mM MgCl 2 , 3 mM Na 2 ATP, 0.1 mM Na 2 GTP, 0.1 mM EGTA, and 5 mM HEPES -KOH buffer, pH 7.2. To measure I Na or I Ca,L , K + ions inside the pipette solution were replaced with equimolar Cs + ions, and the pH was adjusted to 7.2 with CsOH. In some experiments, the pipette was filled with the solution which contained 10 mM DEX.
Cell preparation and differentiation
The clonal strain NG108-15 cell line, formed by Sendai virus-induced fusion of the mouse neuroblastoma clone N18TG-2 and the rat glioma clone C6 BV-1, was obtained from the European Collection of Cell Cultures (ECACC-88112302; Wiltshire, UK). Cells were kept in monolayer cultures at a density of 10 6 ml 21 in plastic disks containing Dulbecco's modified Eagle's medium supplemented with 100 mM hypoxanthine, 1 mM aminopterin, 16 mM thymidine, and 5% fetal bovine serum as the culture medium, in a humidified incubator equilibrated with 90% air/10% CO 2 at 378C.
14 Media were replenished every 2 -3 days with fresh media. To induce neuronal differentiation, culture medium was replaced with medium containing 1 mM dibutyryl cyclic AMP and cells were cultured in the incubator for 1 -7 days. 16 In a separate set of experiments, differentiated NG108-15 cells were preincubated with yohimbine (10 mM) or efaroxan (10 mM) for 5 h before electrophysiological experiments were performed.
Isolation of cerebellar granule cells
Cerebellar granule cells were isolated from Wistar rat pups of post-natal days 9 -10. Cerebella of 5 -7 animals were excised after decapitation, and minced and digested with collagenase (50 mg ml
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) for 10 min. Mechanical trituration with a Pasteur pipette was made in a DNase I/soybean trypsin inhibitor solution. Dissociated cells were centrifuged and suspended in normal Tyrode's solution. Cells were used for experiments within 2 -3 h after isolation. Animal experiments were conducted according to the protocols that follow the NIH standards and the guidelines for the Care and Use of Experimental Animals. The procedure was approved by the Animal Care and Use Committee of the National Cheng Kung University, Tainan, Taiwan, Republic of China.
Electrophysiological measurements
Immediately before each experiment, cells were dissociated and an aliquot of cell suspension was transferred to a recording chamber mounted on the stage of an inverted DM-IL microscope (Leica, Wetzlar, Germany). Cells were bathed at room temperature (20 -258C) in normal Tyrode's solution containing 1.8 mM CaCl 2 . Patch pipettes were pulled from Kimax-51 glass capillaries (Kimble Glass, Vineland, NJ, USA) on a PP-830 microelectrode puller (Narishige, Tokyo, Japan), and their tips were fire-polished Dexmedetomidine inhibits neuronal ion currents with an MF-83 microforge (Narishige). The resistances of the patch pipettes when filled with the internal solutions were between 3 and 5 MV. Ion currents were measured with glass pipettes in a whole-cell configuration of the patch-clamp technique, using an RK-400 patch-clamp amplifier (Biologic, Claix, France). 13 17 Data recordings and analyses Signals were displayed on an HM-507 oscilloscope (Hameg Inc., East Meadow, NY, USA). Data were stored online in a Slimnote VX 3 computer (Lemel, Taipei, Taiwan) at 10 kHz equipped with a Digidata-1322A interface (Molecular Devices, Sunnyvale, CA, USA). Series resistance, in the range of 5 -15 MV, was electronically compensated. Data were analysed by the use of pCLAMP 9.0 software (Molecular Devices), Origin 7.5 software (Microcal Software, Northampton, MA, USA), or custommade macros built in Excel 2007 spreadsheet running on Windows Vista (Microsoft, Redmond, WA, USA). The pCLAMP-generated voltage-step protocols were used to measure the current -voltage (I-V) relations for ion currents. Action potential duration (APD) was measured at 90% of repolarization (APD 90 ).
To evaluate the percentage inhibition of DEX on I K(DR) , NG108-15 cells were bathed in normal Ca 2þ -free Tyrode's solution and each cell was depolarized from 250 to +50 mV. The amplitude of I K(DR) at the end of depolarizing pulse during exposure to different concentrations (0.1 -30 mM) of DEX was measured. Concentration -response data for inhibition of I K(DR) were fitted with a modified form of the Hill equation:
where y is the normalized amplitude of I K(DR) ; [DEX] represents the DEX concentration; and IC 50 and n H are the concentration required for 50% inhibition and Hill coefficient, respectively. Maximal inhibition (i.e. 12a) was also estimated. By the use of a least squares method, the smooth curve shown in Figure 1B was allowed to converge on the experimental data when the maximal block was left undefined. Time constants of current activation (t act ) in the absence or presence of DEX were determined by fitting the trajectory of each current trace with single exponential curves. To determine the effect of DEX on the steady-state inactivation of I K(DR) , the relationship between the conditioning potentials and the normalized amplitude of I K(DR) obtained with or without addition of DEX (3 mM) was fitted by the Boltzmann function:
where I max represents the maximal activated I K(DR) , V is the membrane potential in mV, a the membrane potential for a half-maximal inactivation, and b the slope factor of the inactivation curve of I K(DR) .
Values are provided as means (SEM) with sample sizes (n) indicating the number of cells from which the data were taken. The paired or unpaired Student's t-test and one-way analysis of variance (ANOVA) with the least significant difference method for multiple comparisons were used for the statistical evaluation of differences among means. Non-parametric Kruskal-Wallis test was then used, if the assumption of normality underlying ANOVA was violated. Statistical analyses were performed using SPSS 14.0 (SPSS Inc., Chicago, IL, USA). Statistical significance was determined at a P-value of ,0.05.
Results
Effect of DEX on delayed rectifier K + current [I K(DR) ] in differentiated NG108-15 cells
In an initial set of experiments, a whole-cell configuration of the patch-clamp technique was used to evaluate the effects of DEX on ion currents in NG108-15 cells differentiated with dibutyryl cyclic AMP (1 mM). To record I K(DR) , cells were bathed in Ca 2+ -free Tyrode's solution which contained tetrodotoxin (1 mM) and CdCl 2 (0.5 mM), and the recording pipette was filled with a K + -containing solution. Figure 1 shows that DEX can depress the amplitude of I K(DR) in a concentrationdependent manner. In these experiments, each cell was depolarized from 250 to +50 mV with a duration of 300 ms, and current amplitudes of I K(DR) were measured at the end of depolarizing pulses. DEX (0.1 -30 mM) suppressed the amplitude of I K(DR) in a concentration-dependent manner. The relationship between the DEX concentration and the percentage inhibition of I K(DR) was constructed and plotted in Figure 1B . The IC 50 value for DEX-induced inhibition of I K(DR) was 4.6 mM. Figure 1C illustrates averaged I-V relationships of I K(DR) obtained in the control and during cell exposure to 3 mM DEX. The results demonstrate that DEX has a significant depressant action on I K(DR) functionally expressed in differentiated NG108-15 cells.
Kinetic studies of DEX-induced block of I K(DR)
Because the activation time course of I K(DR) during exposure to DEX tends to be progressively reduced, it is important to determine the kinetics of DEX-induced block in these cells. As shown in Figure 1D , when cells were depolarized from 250 to +50 mV, exposure to DEX was noted to produce a reduction of t act in a concentrationdependent fashion. Therefore, the results suggest that the inhibitory effects of DEX on I K(DR) can be primarily explained by state-dependent blocker where it can bind to the open state of the channel according to the minimal kinetic scheme: (Fig. 1E) . The values were calculated using the relation:
In particular, k 1 and k 21 , respectively, result from the slope and from the y-axis intercept at [D]=0 of the linear In (E), the reciprocal of the activation time constant (t act ), obtained by a single-exponential fit of the increasing phase of I K(DR) , was plotted against the DEX concentration. Data points were fitted by a linear regression, suggesting that the interaction occurs with a stoichiometry of 1. Forward (k 1 ) and reverse (k 21 ) rate constants, given by the slope and the y-axis intercept of the interpolated line, were 0.056 ms 21 
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) of this drug was derived. Notably, this value was found to agree with its IC 50 value determined from the concentration -response curve (Fig. 1B) . However, the backward rate constant (i.e. k 21 ) showed little dependence on the DEX concentration: k 21 was 0.34 ms 21 (n=6) at 1 mM and 0.34 ms 21 (n=6) at 3 mM.
Lack of effect of DEX on steady-state inactivation curve of I K(DR)
To characterize the inhibitory effect of DEX on I K(DR) , we next investigated whether this drug affects the steady-state inactivation curve of I K(DR) in differentiated NG108-15 cells. Figure 2 illustrates the steady-state inactivation curve of I K(DR) obtained in the absence and presence of DEX (3 mM). In these experiments, a 10 s conditioning pulse to different membrane potentials preceded the test pulse to +50 mV from a holding potential of 250 mV. The relationships between the conditioning potentials and the normalized amplitudes of I K(DR) with or without application of DEX (3 mM) were plotted and fitted by the Boltzmann equation as described in Methods. In control, a=212.3 (2.2) mV, b=6.6 (0.8) mV (n=6), whereas in the presence of DEX (3 mM), a=212.1 (2.1) mV, b=6.3 (0.7) mV (n=6). The values for a and b were not significantly modified in the presence of DEX (3 mM), although it reduced the maximal conductance of I K(DR) by about 50%.
Effect of DEX on averaged I-V relations of I K(DR) in NG108-15 cells treated with yohimbine
DEX was reported to be a selective agonist of a 2 -adrenergic receptors. 1 Previous studies showed the ability of yohimbine to reverse both increased K + outward currents and anticonvulsant effect caused by DEX. 5 9 10 We next evaluated whether inhibition of a-adrenergic receptors can influence DEX-induced block of I K(DR) in NG108-15 cells. In these experiments, differentiated NG108-15 cells preincubated with yohimbine (10 mM) for 5 h. Yohimbine is an a 2 -adrenoceptor antagonist, whereas efaroxan is an antagonist of imidazoline-I 1 and a 2 -adrenergic receptors. In yohimbine-treated cells, the inhibitory effect of DEX on the I-V relationship of I K(DR) remained unaltered (Fig. 3) . No significant difference in the magnitude of DEX-induced inhibition of I K(DR) between control cells and cells treated with DEX can be seen. Moreover, subsequent application of yohimbine (10 mM) or efaroxan (10 mM) did not reverse the inhibition of I K(DR) caused by DEX (3 mM) (data not shown). Similarly, in cells treated with efaroxan (10 mM) for 5 h, the magnitude of DEX-induced inhibition of I K(DR) remained unchanged. These results are thus interpreted to mean that the inhibitory effect of DEX on I K(DR) in these cells is unrelated to its binding to a 2 -adrenergic receptors.
Effect of DEX on voltage-gated Na + current (I Na ) in differentiated NG108-15 cells
We next investigated whether DEX has any effects on I Na present in these cells. Cells were bathed in Ca 2+ -free Tyrode's solution containing 0.5 mM CdCl 2 and the pipette was filled with a Cs + -containing solution. The effect of DEX on I Na was examined at different potentials and an I-V relationship of I Na was constructed. As shown in Figure 4 , DEX at a concentration of 10 mM could significantly decrease the peak amplitude of I Na , when cells were depolarizing from 280 mV to different potentials ranging from 280 to +40 mV. For example, when the cell was depolarized from 280 to 240 mV, application of DEX (10 mM) significantly decreased I Na from 0.79 (0.07) to 0.62 (0.07) nA (n=7). After washout of the drug, I Na was returned to 0.76 (0.06) nA (n=6). However, the overall I-V configuration of I Na did not differ between the absence and the presence of DEX. A subsequent application of yohimbine (10 mM) did not reverse the inhibition of I Na caused by DEX (data not shown).
Lack of effect of DEX on L-type Ca 2+ current (I Ca,L ) in differentiated NG108-15 cells
Previous reports showed that DEX is able to modify Ca 2+ current in phaeochromocytoma cells. 7 We also determined the ability of this agent to alter the amplitude of I Ca,L in these cells. The experimental results are illustrated in Figure 5 . When the cell was depolarized from 240 to different potentials ranging from 240 to +40 mV, the peak amplitude of I Ca,L was not found to differ between the absence and the presence of 10 mM DEX. Moreover, when cells were exposed to this agent, no modification of the I-V relationship of I Ca,L can be demonstrated. Therefore, unlike I Na , I Ca,L is relatively insensitive to inhibition by DEX in these cells.
Effect of DEX on action potentials in differentiated NG108-15 cells
In another set of experiments, we determined the ability of DEX to alter membrane potential. In these experiments, cells were bathed in normal Tyrode's solution containing n=6-11) . DEX reduced the peak amplitude of I Na with no change in the overall I-V configuration. Dexmedetomidine inhibits neuronal ion currents DEX. The widening of APs caused by DEX could be primarily explained by its block of I K(DR) and I Na , but not by the activation of I Ca,L .
Inhibitory effects of DEX on ion currents in response to AP waveforms in differentiated NG108-15 cells
The size and time course of ion currents [e.g. I Na and I K(DR) ] in response to change in AP waveforms tend to be different from those elicited by rectangular voltage-clamp pulses. The effects of DEX on ion currents during APs generated from NG108-15 cells were also investigated. In these experiments, cells were bathed in normal Tyrode's solution, and the waveforms of APs were digitally generated as voltage templates and replayed to evoke ion currents. 19 As shown in Figure 7 , the amplitudes of I Na and I K(DR) in response to AP waveforms were reduced in the presence of DEX. For example, after application of 1 mM DEX, the peak amplitude of I Na elicited by the waveforms of APs was decreased by about 10%. Moreover, I K(DR) in response to AP waveforms was suppressed by about 30%. The results led us to suggest that I Na and I K(DR) evoked by AP waveforms are more sensitive to block by this agent than those during rectangular pulses.
Effect of DEX on I K(DR) in isolated rat cerebellar granule cells
Previous studies have demonstrated the presence of I K(DR) (i.e. K V 3.3-encoded current) in cerebellar granule cells. 20 DEX was shown to influence the cyclic GMP effector system in the mouse cerebellum. 21 Therefore, to verify whether the DEX-induced inhibition of I K(DR) could also be observed in another type of cells, we also investigated the effect of DEX on I K(DR) in isolated cerebellar granular cells. In isolated cerebellar granule cells, the I K(DR) , which was clearly identified as a slowly inactivating I K(DR) , could be elicited. As shown in Figure 8 , DEX was effective in suppressing I K(DR) found in these cells. When depolarizing pulses from -50 to +50 mV were applied, DEX (30 mM) significantly decreased current amplitude at the end of the voltage pulses from 2018 (152) to 1196 (81) pA (n=7). Consistent with the observations made in differentiated NG108-14 cells, these data indicate that DEX is capable of inducing the block of I K(DR) and increasing current activation in cerebellar granule cells.
Discussion
The present results demonstrate that in differentiated NG108-15 neuronal cells, DEX produces a depressant action on I K(DR) in a concentration-and state-dependent fashion. DEX also blocks the peak amplitude of I Na , whereas it had little or no effect on I Ca,L . This study suggests that the exposure to this agent can produce inhibitory effects on I K(DR) and I Na . In addition to activation of a 2 -adrenergic receptors, DEX-induced block of these currents could thus be potential mechanisms through which it may depress neuronal excitability.
A notable feature of the block of I K(DR) by DEX in NG108-15 cells is that the activating phase of the current (i.e. activation time course) was elevated in the presence of this agent. At the beginning of the depolarizing stimuli, dI/dt is proportional to the number of channels available for activation. However, it will remain to be determined whether other types of K DR channels can be differentially subject to block by this drug or other structurally related compounds.
We provide the direct evidence that DEX has a depressant action on I K(DR) in differentiated NG108-15 cells. The half-blocking concentration of DEX required for inhibition of I K(DR) with an IC 50 value of 4.6 mM appears to be of the same order of magnitude as the concentration used elicit outward K + currents in other types of neurones. 9 10 The concentration used in this study tends to be greater than mean plasma concentration during sedation (0.9 -2.3 ng ml
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; 4-10 nM). 22 -24 However, the concentration immediately after a bolus of injection with DEX can range between 0.1 and 1 mM. 22 -24 Individual patients can differ physiologically owing to differences in regional blood flow or volume of distribution. 24 25 Moreover, the I K(DR) and I Na in response to AP waveforms were more sensitive to block by DEX than those evoked by rectangular pulses. 
Dexmedetomidine inhibits neuronal ion currents
The K DR channels may thus be an important target for the action of this agent. Both the alterations in the channel gating and the reduction of the currents caused by this agent are also likely to be clinically relevant, if similar results are found in intact neurones in vivo. To what extent block of I K(DR) presented here contribute to the unusual subcortical form of DEX-induced sedation 3 also remains to be further elucidated.
Intracellular dialysis with 10 mM DEX had little or no effects on I K(DR) or I Na in differentiated NG108-15 cells. Although its detailed mechanisms are unclear, the site of DEX action could be localized mainly on the extracellular side of the channel molecule near the outer channel mouth. Moreover, previous studies showed that in hypothalamic paraventricular nucleus neurones, DEX (0.1 -20 mM) suppressed hyperpolarization-elicited inward current and activated G-proteins-coupled inwardly rectifying K + currents, and yohimbine antagonized DEX-induced effects. 9 However, in the present study, in cells treated with yohimbine or efaroxan, DEX-induced inhibition of I K(DR) was unaltered. Therefore, block by this agent of I K(DR) or I Na in differentiated NG108-15 neuronal cells appears to be direct and is unlikely to be mediated through binding to a 2 -adrenergic receptors.
Previous reports at our laboratory demonstrated the ability of propofol to reduce the amplitude of I Ca,L in H9c2 myoblasts. 26 However, in this study, little or no effects of DEX on I Ca,L was observed in differentiated NG108-15 cells. The observations seem to be different from earlier studies showing the ability of this agent to modify the amplitude of I Ca,L in phaeochromocytoma cells treated with nerve growth factor. 7 This discrepancy is currently unclear; however, it could be due to the fact that there are different types of Ca 2+ channel-forming subunits in different cell types. The Ca V 1.3 (a 1D ) Ca 2+ channelforming subunit is predominantly expressed in NG108-15 cells. 27 It has been reported that K V 3.1, one of the Shaw-type K + channels, is the major molecular component of I K(DR) in differentiated NG108-15 cells. 12 -14 A partial block of the classical Hodgkin -Huxley-type K + current leads to the increased number of evoked APs, whereas a partial block of the slowly inactivating I K(DR) (e.g. K V 3.1-encoded current) can decrease the number of evoked APs. 28 Through an inhibition of I K(DR) presented here, DEX can depolarize the cell and exacerbate the inhibition of I Na to a greater extent, thereby diminishing its depressant action on I Na . Therefore, the block by DEX of I K(DR) at depolarizing potentials can delay repolarization, which could cause a reduction in neuronal excitability.
Besides its action at a 2 -adrenergic receptors, DEX exhibits some affinity for imidazoline binding sites. 29 Previous studies in isolated portal vein cells have demonstrated that several agents containing an imidazoline moiety can induce the inhibition of I K(DR) . 30 DEX was recently reported to increase the expression of phosphorylated extracellular signal-regulated kinases via a mechanism linked to its binding to imidazoline I 1 receptors. 31 It is thus possible that DEX exerts its inhibitory effects on I K(DR) by an interaction with an imidazoline binding site. It also remains to be clarified whether levomedetomidine, an inactive isomer of DEX, 22 has any effect on I K(DR) , although this agent showed little pharmacological action. In summary, the inhibitory effect of DEX on I K(DR) in NG108-15 cells and in isolated cerebellar granule cells is not associated with binding to a 2 -adrenergic receptors. Because of the importance of I K(DR) (i.e. K V 3.1-encoded current) in contributing to excitability and automaticity of neuronal cells, these effects shown in this study could provide novel insights into electrophysiological properties of DEX and other structurally related compounds.
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